Mapping the human mucosal immune response to respiratory viruses

Mapping the human mucosal immune response
to respiratory viruses

Conventionally, human immune responses have been extensively characterized using blood. Immune cells, though abundant in blood, are also found in various tissues in varying numbers and with locally relevant functional specification. Assessing immune responses in the airways over the course of infection and convalescence is critical to comprehensively mapping immunity to respiratory viral infections including influenza and SARS-CoV-2.

In a study recently published in eLife, Sindhu Vangeti, PhD, and colleagues at the Icahn School of Medicine at Mount Sinai, demonstrated that innate immune cells, like monocytes and dendritic cells, possess unique dynamics defined by location and pathogen. In addition to characterizing immune cells in blood, the team also investigated immune cell distribution and function in the human nasopharynx.

Learn about:

  • Monocytes and dendritic cells in human respiratory viral infections.
  • Studying immune responses in the human airways.
  • Integrating state-of-the-art platforms into conventional study design.

Image of Sindhu Vangeti

Sindhu Vangeti, PhD

Sindhu Vangeti, PhD, is a postdoctoral fellow in Irene Ramos’s viral immunology team in the Stuart C. Sealfon lab at the Icahn School of Medicine at Mount Sinai. Currently, her research focuses on mapping the epigenetic fingerprint of influenza/SARS-CoV-2 exposure and studying mechanisms that lead to durability of vaccine-induced immunity. Dr. Vangeti obtained her doctorate in 2019 at the Karolinska Institutet in the lab of Anna Smed Sörensen, studying human immune responses to influenza and hantavirus infections.

Mapping the human mucosal immune response to respiratory viruses

A presentation by Sindhu Vangeti, PhD

More resources for immunology research

What can proteomics teach us about infectious disease?

Watch webinar

Tech Note:
SomaScan Assay v4.1 signaling in mouse plasma


Case studies:
Massive-scale proteomics for COVID-19

Learn more

White paper:
COVID-19 and the SomaScan® Platform


Search our publications viewer

Search our extensive database of peer-reviewed research on the use of the SomaScan® Platform by entering keywords to narrow your search, such as influenza, COVID, or respiratory.

See publications

Share with colleagues

More webinars

WebinarBoutique Webinar Aptamers with protein-like side chains as a versatile tool for high-content proteomics

Proteins, encoded in 20,000 genes in humans, do much of the work in biology. Measuring proteins, which change in response to various perturbations and represent targets for almost all drugs, offers insights about the health status of an organism. Since proteins operate in complex networks rather than in isolation, measuring multiple proteins simultaneously offers richer insights compared to single protein measurements.

Learn more

WebinarUsing Proteomics To Advance Understanding of Alzheimer’s Disease 

Limited understanding due to its complex pathophysiology and lack of definitive biomarkers currently constrains the diagnosis and treatment of Alzheimer’s disease (AD). But new research is uncovering dynamic brain changes during Alzheimer’s progression, offering potential therapeutic targets. This webinar explores how proteomics and systems biology can be integrated to elucidate AD pathology.

Learn more

WebinarPredictive modeling and reliable biomarker discovery in clinical omics studies 

High-content omic technologies coupled machine learning methods have transformed the biomarker discovery process. However, the translation of computational results into scalable clinical biomarkers remains challenging. A rate-limiting step is the rigorous selection of reliable biomarker candidates among a host of biological features. Drawing examples from real-world clinical omics studies, I will introduce Stabl, a general machine learning framework that identifies a sparse, reliable set of biomarkers by integrating noise injection and a data-driven signal-to-noise threshold into multivariable predictive modeling.

Learn more

Explore webinars in our interactive viewer